DAA药物-话题@MedSci

#DAA药物#

8篇内容 | 591人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1952111, encodeId=e34a1952111e3, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, objectType=article, longId=145194, objectId=003414519441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003414519441, replyNumber=0, likeNumber=39, createdTime=2019-02-06, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003414519441, moduleTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003414519441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952109, encodeId=736719521090c, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=J Hepatol：DAA药物提高了早期肝移植患者生存率和改善了肝移植候补患者病情, objectType=article, longId=130865, objectId=325d1308653c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=325d1308653c, replyNumber=0, likeNumber=38, createdTime=2018-05-26, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=325d1308653c, moduleTitle=J Hepatol：DAA药物提高了早期肝移植患者生存率和改善了肝移植候补患者病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=325d1308653c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952110, encodeId=03e0195211063, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=J Viral Hepat：在日本，采用口服DAA药物治疗HCV基因1b型患者，显著增加了直接和间接经济效益, objectType=article, longId=131014, objectId=e69813101429, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e69813101429, replyNumber=0, likeNumber=28, createdTime=2018-05-10, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69813101429, moduleTitle=J Viral Hepat：在日本，采用口服DAA药物治疗HCV基因1b型患者，显著增加了直接和间接经济效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e69813101429)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952108, encodeId=1dfe1952108fe, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=《欧洲肝肠移植协会（ELITA）关于DAA药物在肝移植术前及术后应用的共识意见》介绍, objectType=article, longId=126542, objectId=91c012654208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91c012654208, replyNumber=0, likeNumber=23, createdTime=2018-07-11, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91c012654208, moduleTitle=《欧洲肝肠移植协会（ELITA）关于DAA药物在肝移植术前及术后应用的共识意见》介绍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91c012654208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952107, encodeId=c34e195210efc, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好, objectType=article, longId=123103, objectId=43c5123103be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c5123103be, replyNumber=0, likeNumber=35, createdTime=2018-04-22, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c5123103be, moduleTitle=Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43c5123103be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952106, encodeId=1876195210616, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率, objectType=article, longId=92953, objectId=c41492953b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c41492953b7, replyNumber=0, likeNumber=0, createdTime=2018-02-20, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c41492953b7, moduleTitle=Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c41492953b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952105, encodeId=ec6419521054e, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=治愈丙肝重磅新药将上市！本土DAA药物突围, objectType=article, longId=85913, objectId=382185913a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=382185913a3, replyNumber=0, likeNumber=29, createdTime=2017-04-17, rootId=0, userName=经常头晕, userId=8f14236, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=382185913a3, moduleTitle=治愈丙肝重磅新药将上市！本土DAA药物突围, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=382185913a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1952104, encodeId=4920195210417, content=<a href='/topic/show?id=50705650a2' target=_blank style='color:#2F92EE;'>#DAA药物#</a>, objectTitle=DAA药物，逐一细说, objectType=article, longId=29417, objectId=8d672941e95, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d672941e95, replyNumber=0, likeNumber=0, createdTime=2014-09-03, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d672941e95, moduleTitle=DAA药物，逐一细说, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d672941e95)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DAA药物

2020-05-29

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化

2019-02-06

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

J Hepatol：DAA药物提高了早期肝移植患者生存率和改善了肝移植候补患者病情

2018-05-26

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

J Viral Hepat：在日本，采用口服DAA药物治疗HCV基因1b型患者，显著增加了直接和间接经济效益

2018-05-10

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

《欧洲肝肠移植协会（ELITA）关于DAA药物在肝移植术前及术后应用的共识意见》介绍

2018-07-11

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好

2018-04-22

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率

2018-02-20

经常头晕 (审核中...)

前往app查看评论内容

#DAA药物#

治愈丙肝重磅新药将上市！本土DAA药物突围

2017-04-17

智慧医人 (审核中...)

前往app查看评论内容

#DAA药物#

DAA药物，逐一细说

2014-09-03

科室
- - 订阅+
  - 更多科室
工具
服务